Target intelligence / Profile preview

T-cell receptor recognizing influenza virus-derived peptide–MHC-II complexes (Influenza-specific TCR)

Target
Influenza-specific TCR
Molecular classification
T-cell receptor, Receptor, Antigen-specific receptor, Heterodimeric protein
01

Overview

The T-cell receptor (TCR) recognizing influenza virus-derived peptide–MHC-II complexes is a specialized alpha-beta (αβ) heterodimer found on the surface of CD4+ T helper cells. It plays a pivotal role in the adaptive immune response by specifically identifying viral antigens, most notably the immunodominant hemagglutinin (HA) peptide (residues 306-318), when presented by Major Histocompatibility Complex class II (MHC-II) molecules such as HLA-DR1 or HLA-DR4 (Reinherz et al., 1999; Hennecke et al., 2000). This molecular recognition event is the primary trigger for T-cell activation, leading to the secretion of cytokines like interferon-gamma (IFN-γ) and providing the necessary signals for B-cell maturation and antibody production (Brown et al., 1991). In therapeutic contexts, these TCRs are the focus of TCR-engineered T-cell (TCR-T) therapies and the design of epitope-specific vaccines aimed at providing broad protection against various influenza strains (NIH, 2023). Structural studies of the HA1.7 TCR clone have provided fundamental insights into how the immune system discriminates between viral and self-peptides, which is essential for minimizing off-target effects and developing safe immunotherapies (PubMed, 1717572). Understanding the structural basis of this interaction is vital for predicting cross-reactivity and improving the efficacy of seasonal and universal influenza vaccines.

Other names
Influenza-specific CD4+ T-cell receptorHA-specific T-cell receptorHA1.7 TCRHemagglutinin-specific T-cell receptorInfluenza-specific TCRαβ
02

Mechanism of action

The T-cell receptor (TCR) specifically recognizes and binds to an influenza-derived peptide, such as the immunodominant hemagglutinin (HA) 306-318 epitope, when it is presented by Major Histocompatibility Complex class II (MHC-II) molecules (e.g., HLA-DR1 or HLA-DR4) on the surface of antigen-presenting cells. This binding event, stabilized by the CD4 co-receptor, triggers the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) within the associated CD3 complex. This initiates a downstream signaling cascade involving ZAP-70 and PLC-gamma-1, leading to T-cell proliferation, the secretion of pro-inflammatory cytokines like IFN-gamma, and the coordination of the adaptive immune response to clear the viral infection.

03

Biological functions

Antigen recognitionT-cell activationImmune responseCytokine productionAdaptive immunityB-cell help
04

Disease associations

InfectionInfluenzaInflammation
05

Safety considerations

Cross-reactivity with self-antigens (molecular mimicry)Cytokine release syndrome (CRS)Viral escape through epitope mutationOff-target activation
06

Interacting drugs

Muromonab-CD3

3 more in the full profile.

07

Biomarkers

MHC-II tetramer positivity (e.g., HLA-DRB1*04:01/HA306-318)CD69 expressionInterferon-gamma (IFN-gamma) productionCD154 (CD40L) expressionTCR V-beta repertoire analysis

Beyond the preview

Go deeper on T-cell receptor recognizing influenza virus-derived peptide–MHC-II complexes (Influenza-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing influenza virus-derived peptide–MHC-II complexes (Influenza-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call